Northeast Financial Consultants’s Ionis Pharmaceuticals IONS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,740	Closed	-$277K	–	310
2023 Q1	$277K	Hold	7,740	–	–	0.02%	253
2022 Q4	$292K	Hold	7,740	–	–	0.02%	247
2022 Q3	$342K	Hold	7,740	–	–	0.03%	245
2022 Q2	$287K	Hold	7,740	–	–	0.02%	263
2022 Q1	$287K	Hold	7,740	–	–	0.02%	313
2021 Q4	$236K	Hold	7,740	–	–	0.01%	312
2021 Q3	$260K	Hold	7,740	–	–	0.02%	298
2021 Q2	$309K	Hold	7,740	–	–	0.02%	279
2021 Q1	$348K	Hold	7,740	–	–	0.03%	249
2020 Q4	$438K	Hold	7,740	–	–	0.04%	210
2020 Q3	$367K	Hold	7,740	–	–	0.03%	204
2020 Q2	$456K	Hold	7,740	–	–	0.04%	177
2020 Q1	$366K	Hold	7,740	–	–	0.04%	186
2019 Q4	$468K	Sell	7,740 -260	-3%	-$15.7K	0.04%	188
2019 Q3	$479K	Hold	8,000	–	–	0.05%	185
2019 Q2	$514K	Buy	8,000 +37	+0.5%	+$2.38K	0.05%	182
2019 Q1	$646K	Buy	+7,963	New	+$646K	0.07%	154
2018 Q3	–	Sell	-7,703	Closed	-$320K	–	159
2018 Q2	$320K	Hold	7,703	–	–	0.1%	112
2018 Q1	$339K	Hold	7,703	–	–	0.11%	111
2017 Q4	$387K	Hold	7,703	–	–	0.13%	102
2017 Q3	$391K	Hold	7,703	–	–	0.14%	103
2017 Q2	$392K	Hold	7,703	–	–	0.15%	100
2017 Q1	$310K	Hold	7,703	–	–	0.13%	114
2016 Q4	$368K	Hold	7,703	–	–	0.16%	104
2016 Q3	$282K	Buy	+7,703	New	+$282K	0.12%	122
2015 Q3	–	Sell	-3,817	Closed	-$220K	–	145
2015 Q2	$220K	Hold	3,817	–	–	0.1%	137
2015 Q1	$243K	Hold	3,817	–	–	0.11%	120
2014 Q4	$236K	Buy	+3,817	New	+$236K	0.12%	111